JESSICA HATHAWAY: Open Payments
NPI 1366114746 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 60 payments from 21 companies in 2025. Trend: 2023 $2,519 · 2024 $2,696 · 2025 $1,305
Food & beverage: $1,305
| Company | Payments | Amount |
|---|---|---|
| Olympus America Inc. | 11 | $234 |
| Sumitomo Pharma America, Inc. | 11 | $174 |
| Janssen Biotech, Inc. | 8 | $151 |
| Merck Sharp & Dohme LLC | 4 | $111 |
| Boston Scientific Corporation | 1 | $99 |
| UROGEN PHARMA, INC. | 3 | $91 |
| COLOPLAST CORP | 4 | $86 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $49 |
| Verity Pharmaceuticals Inc. | 2 | $43 |
| Antares Pharma, Inc. | 2 | $41 |
Products named: iTIND System, ERLEADA, GEMTESA, KEYTRUDA, Axonics, JELMYTO, ORGOVYX, Personal Catheter Intermittent Catheter.
Industry payments across MI — which companies pay providers there.
